Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: data of the Post-Hoc Analysis of a Nationwide Study

Rokszin, GyörgyKiss, ZoltánSütő, GáborKempler, PéterJermendy, GyörgyFábián, IbolyaSzekanecz, ZoltánPoór, GyulaWittmann, IstvánMolnár, Gergő Attila2021-10-292021-10-292021Frontiers in Oncology. -11 (2021), p. 1-9. -(cikkazonosító)725465. -Front Oncol. - 2234-943X2234-943Xhttp://hdl.handle.net/2437/323806Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: data of the Post-Hoc Analysis of a Nationwide Studyfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM097681OrvostudományokKlinikai orvostudományokhttps://www.frontiersin.org/articles/10.3389/fonc.2021.725465/fullhttp://dx.doi.org/10.3389/fonc.2021.7254652022-03-2300071770180000185118968206